These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 25065845

  • 1. Phosphorylated neurofilament subunit NF-H becomes elevated in the cerebrospinal fluid of patients with acutely worsening symptoms of compression myelopathy.
    Takahashi H, Aoki Y, Nakajima A, Sonobe M, Terajima F, Saito M, Taniguchi S, Yamada M, Watanabe F, Furuya T, Koda M, Yamazaki M, Takahashi K, Nakagawa K.
    J Clin Neurosci; 2014 Dec; 21(12):2175-8. PubMed ID: 25065845
    [Abstract] [Full Text] [Related]

  • 2. Axonal damage is remarkable in patients with acutely worsening symptoms of compression myelopathy: biomarkers in cerebrospinal fluid samples.
    Takahashi H, Aoki Y, Nakajima A, Sonobe M, Terajima F, Saito M, Miyamoto T, Koyama K, Yamamoto K, Furuya T, Koda M, Ohtori S, Yamazaki M, Nakagawa K.
    Eur Spine J; 2018 Aug; 27(8):1824-1830. PubMed ID: 29557051
    [Abstract] [Full Text] [Related]

  • 3. Phosphorylated neurofilament subunit levels in the serum of cervical compressive myelopathy patients.
    Kato S, Chikuda H, Ohya J, Hayakawa K, Takeshita K, Tanaka S, Ogata T.
    J Clin Neurosci; 2015 Oct; 22(10):1638-42. PubMed ID: 26195334
    [Abstract] [Full Text] [Related]

  • 4. Phosphorylated neurofilament subunit NF-H as a biomarker for evaluating the severity of spinal cord injury patients, a pilot study.
    Hayakawa K, Okazaki R, Ishii K, Ueno T, Izawa N, Tanaka Y, Toyooka S, Matsuoka N, Morioka K, Ohori Y, Nakamura K, Akai M, Tobimatsu Y, Hamabe Y, Ogata T.
    Spinal Cord; 2012 Jul; 50(7):493-6. PubMed ID: 22270191
    [Abstract] [Full Text] [Related]

  • 5. Serum oxidative stress influences neurological recovery after surgery to treat acutely worsening symptoms of compression myelopathy: a cross-sectional human study.
    Takahashi H, Aoki Y, Saito J, Nakajima A, Sonobe M, Akatsu Y, Taniguchi S, Yamada M, Koyama K, Akiyama Y, Shiga Y, Inage K, Orita S, Eguchi Y, Maki S, Furuya T, Akazawa T, Koda M, Yamazaki M, Ohtori S, Nakagawa K.
    BMC Musculoskelet Disord; 2019 Dec 07; 20(1):589. PubMed ID: 31810443
    [Abstract] [Full Text] [Related]

  • 6. Cerebrospinal Fluid Levels of Phosphorylated Neurofilament Heavy as a Diagnostic Marker of Canine Degenerative Myelopathy.
    Toedebusch CM, Bachrach MD, Garcia VB, Johnson GC, Katz ML, Shaw G, Coates JR, Garcia ML.
    J Vet Intern Med; 2017 Mar 07; 31(2):513-520. PubMed ID: 28186658
    [Abstract] [Full Text] [Related]

  • 7. CSF neurofilament proteins as diagnostic and prognostic biomarkers for amyotrophic lateral sclerosis.
    Rossi D, Volanti P, Brambilla L, Colletti T, Spataro R, La Bella V.
    J Neurol; 2018 Mar 07; 265(3):510-521. PubMed ID: 29322259
    [Abstract] [Full Text] [Related]

  • 8. Elevated levels of phosphorylated neurofilament heavy subunit in the cerebrospinal fluid of patients with lumbar spinal stenosis: preliminary findings.
    Ohya J, Chikuda H, Kato S, Hayakawa K, Oka H, Takeshita K, Tanaka S, Ogata T.
    Spine J; 2015 Jul 01; 15(7):1587-92. PubMed ID: 25797810
    [Abstract] [Full Text] [Related]

  • 9. Parallel Cerebrospinal Fluid and Serum Temporal Profile Assessment of Axonal Injury Biomarkers Neurofilament-Light Chain and Phosphorylated Neurofilament-Heavy Chain: Associations With Patient Outcome in Moderate-Severe Traumatic Brain Injury.
    Wang KKW, Barton DJ, McQuillan LE, Kobeissy F, Cai G, Xu H, Yang Z, Trifilio E, Williamson JB, Rubenstein R, Robertson CS, Wagner AK.
    J Neurotrauma; 2024 Jul 01; 41(13-14):1609-1627. PubMed ID: 38588256
    [Abstract] [Full Text] [Related]

  • 10. Phosphorylated neurofilament H (pNF-H) as a potential diagnostic marker for neurological disorders in horses.
    Intan-Shameha AR, Divers TJ, Morrow JK, Graves A, Olsen E, Johnson AL, Mohammed HO.
    Res Vet Sci; 2017 Oct 01; 114():401-405. PubMed ID: 28750210
    [Abstract] [Full Text] [Related]

  • 11. Hyperphosphorylated neurofilament NF-H is a serum biomarker of axonal injury.
    Shaw G, Yang C, Ellis R, Anderson K, Parker Mickle J, Scheff S, Pike B, Anderson DK, Howland DR.
    Biochem Biophys Res Commun; 2005 Nov 04; 336(4):1268-77. PubMed ID: 16176808
    [Abstract] [Full Text] [Related]

  • 12. Phosphorylated neurofilament heavy subunit (pNF-H) in peripheral blood and CSF as a potential prognostic biomarker in amyotrophic lateral sclerosis.
    Boylan KB, Glass JD, Crook JE, Yang C, Thomas CS, Desaro P, Johnston A, Overstreet K, Kelly C, Polak M, Shaw G.
    J Neurol Neurosurg Psychiatry; 2013 Apr 04; 84(4):467-72. PubMed ID: 23117489
    [Abstract] [Full Text] [Related]

  • 13. Cerebrospinal fluid levels of GFAP and pNF-H are elevated in patients with chronic spinal cord injury and neurological deterioration.
    Holmström U, Tsitsopoulos PP, Holtz A, Salci K, Shaw G, Mondello S, Marklund N.
    Acta Neurochir (Wien); 2020 Sep 04; 162(9):2075-2086. PubMed ID: 32588294
    [Abstract] [Full Text] [Related]

  • 14. Predictive value of phosphorylated axonal neurofilament subunit H for clinical outcome in patients with acute intracerebral hemorrhage.
    Cai JY, Lu C, Chen MH, Ba HJ, Chen XD, Lin JH, Sun J.
    Clin Chim Acta; 2013 Sep 23; 424():182-6. PubMed ID: 23810564
    [Abstract] [Full Text] [Related]

  • 15. Cerebrospinal fluid light and heavy neurofilaments in neuromyelitis optica.
    Wang H, Wang C, Qiu W, Lu Z, Hu X, Wang K.
    Neurochem Int; 2013 Dec 23; 63(8):805-8. PubMed ID: 24161620
    [Abstract] [Full Text] [Related]

  • 16. The natural history of asymptomatic lumbar canal stenosis in patients undergoing surgery for cervical myelopathy.
    Tsutsumimoto T, Shimogata M, Yui M, Ohta H, Misawa H.
    J Bone Joint Surg Br; 2012 Mar 23; 94(3):378-84. PubMed ID: 22371547
    [Abstract] [Full Text] [Related]

  • 17. Elevated levels of phosphorylated neurofilament proteins in cerebrospinal fluid of Alzheimer disease patients.
    Hu YY, He SS, Wang XC, Duan QH, Khatoon S, Iqbal K, Grundke-Iqbal I, Wang JZ.
    Neurosci Lett; 2002 Mar 08; 320(3):156-60. PubMed ID: 11852185
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of serum phosphorylated neurofilament subunit NF-H as a prognostic biomarker in dogs with thoracolumbar intervertebral disc herniation.
    Nishida H, Nakayama M, Tanaka H, Kamishina H, Izawa T, Hatoya S, Sugiura K, Suzuki Y, Ide C, Inaba T.
    Vet Surg; 2014 Mar 08; 43(3):289-93. PubMed ID: 24467275
    [Abstract] [Full Text] [Related]

  • 19. Cerebrospinal fluid biomarkers of white matter injury and astrogliosis are associated with the severity and surgical outcome of degenerative cervical spondylotic myelopathy.
    Tsitsopoulos PP, Mondello S, Holmström U, Marklund N.
    Spine J; 2022 Nov 08; 22(11):1848-1856. PubMed ID: 35753639
    [Abstract] [Full Text] [Related]

  • 20. Diagnostic Value of Serum Levels of GFAP, pNF-H, and NSE Compared With Clinical Findings in Severity Assessment of Human Traumatic Spinal Cord Injury.
    Ahadi R, Khodagholi F, Daneshi A, Vafaei A, Mafi AA, Jorjani M.
    Spine (Phila Pa 1976); 2015 Jul 15; 40(14):E823-30. PubMed ID: 25341992
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.